US 11453655
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
granted A61PA61P11/00
Quick answer
US patent 11453655 (Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P11/00